Back to Search Start Over

Multicenter prospective cohort study of adverse events associated with biliary endoscopic retrograde cholangiopancreatography: Incidence of adverse events and preventive measures for post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors :
Fujita K
Yazumi S
Matsumoto H
Asada M
Nebiki H
Matsumoto K
Maruo T
Takenaka M
Tomoda T
Onoyama T
Kurita A
Ueki T
Katayama T
Kawamura T
Kawamoto H
Source :
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society [Dig Endosc] 2022 Sep; Vol. 34 (6), pp. 1198-1204. Date of Electronic Publication: 2022 Feb 04.
Publication Year :
2022

Abstract

Objectives: The reported incidence of adverse events (AEs) in endoscopic retrograde cholangiopancreatography (ERCP) varies between 2.5% and 14%. The aim of this study was to evaluate the incidence and severity of AEs in biliary ERCP and to specify the risk factors and preventive measures for post-ERCP pancreatitis (PEP).<br />Methods: Patients with biliary disease with intact papilla were prospectively enrolled at 36 hospitals between April 2017 and March 2018. The primary outcomes were the incidence and severity of AEs.<br />Results: A total of 16,032 ERCP procedures were performed at the 36 hospitals during the study period and 3739 patients were enrolled. The overall incidence of AEs was 10.1% and ERCP-related mortality was 0.08%. PEP developed in 258 cases (6.9%), bleeding in 33 (0.9%), instrumental AEs in 17 (0.5%), infections in 37 (1.0%), cardiovascular AEs in eight (0.2%), pulmonary AEs in eight (0.2%), drug reaction AE in one (0.03%), pain in 15 (0.4%), and other AEs in 15 (0.4%). Multivariable analysis showed significant risk factors for PEP were: female of younger age, pancreatic guidewire-assisted biliary cannulation, temporary guidewire insertion into the pancreatic duct, total procedure time >60 min, and post-ERCP administration of non-steroidal anti-inflammatory drugs. Effective preventive measures were prophylactic pancreatic stenting (PPS) and epinephrine spraying onto the papilla.<br />Conclusions: In patients with intact papilla who underwent biliary ERCP, the incidence of AEs was 10.1% and the mortality was 0.08%. PPS and epinephrine spraying may prevent PEP.<br />Registration: This study was registered in the University Hospital Medical Information Network (UMIN000024820).<br /> (© 2021 The Authors. Digestive Endoscopy published by John Wiley & Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.)

Details

Language :
English
ISSN :
1443-1661
Volume :
34
Issue :
6
Database :
MEDLINE
Journal :
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society
Publication Type :
Academic Journal
Accession number :
34963021
Full Text :
https://doi.org/10.1111/den.14225